Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Jul 20, 2026
Crown Holdings (CCK) Earnings Preview: What to Watch in the Q2 2026 Report

Crown Holdings (CCK) Earnings Preview: What to Watch in the Q2 2026 Report

Key Takeaways

  • Crown Holdings is scheduled to report second-quarter 2026 earnings after market close on July 20, 2026, with a conference call the following morning.
  • Investors will focus on revenue trends in the company’s global packaging segments amid ongoing demand shifts in beverage and food markets.
  • Analyst consensus expectations center on year-over-year comparisons to prior periods, including margin performance and cost management.
  • Guidance updates, if provided, are expected to address the remainder of the fiscal year and any impacts from raw material pricing.
  • Historical stock reactions to earnings have varied based on how results align with or deviate from consensus forecasts.
  • Broader industry conditions in metal and plastic packaging continue to influence investor sentiment heading into the report.

Why This Earnings Report Matters

Crown Holdings, Inc. operates as a leading global supplier of metal packaging products for beverage, food, and other consumer goods. The second quarter ended June 30, 2026, represents a key reporting period that typically reflects seasonal patterns in the packaging industry. Recent quarters have shown the company navigating fluctuating input costs and evolving customer demand. Earnings results often provide insight into operational efficiency, segment performance across regions, and the company’s ability to maintain pricing discipline. For investors, this report serves as an important checkpoint on execution against strategic priorities and offers clues about near-term business momentum in a competitive sector. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

What Analysts Are Expecting

Analysts will compare results to the first quarter of 2026, which was reported in late April. Key metrics under scrutiny include consolidated revenue, earnings per share, and segment-level operating performance. Investors typically monitor volume trends in the Americas and Europe, as well as any commentary on raw material costs such as aluminum and steel. Historical patterns show that beats or misses relative to consensus estimates can influence subsequent trading sessions. The company has not issued specific numerical guidance in advance of the report, so attention will center on management’s qualitative outlook during the conference call. From what I see, these comparisons will be central to assessing whether the business is stabilizing or facing continued pressure.

Market Sentiment and Potential Reactions

Heading into the earnings release, market sentiment reflects cautious optimism tempered by macroeconomic uncertainties affecting consumer packaging demand. Traders often position ahead of the report, leading to increased volatility in the days surrounding the announcement. Historical price movements following past earnings have depended on the magnitude of any revenue or margin surprises, as well as forward commentary on cost pressures and end-market conditions. A measured reaction is common when results align closely with expectations, while larger deviations can trigger sharper moves as investors reassess valuation multiples. I’m watching this closely because past reactions have shown how sensitive the stock can be to even modest surprises.

Looking Ahead: Factors to Monitor

Following the earnings release, attention will shift to management’s comments on the balance of 2026. Key areas include potential updates on capital expenditure plans, share repurchase activity, and any adjustments to dividend policy.

Investors should also watch for signals regarding volume recovery in key end markets and the company’s progress on sustainability initiatives, which remain central to long-term strategy.

Raw material price trends and foreign currency movements will likely feature in the discussion, given their historical impact on margins. Supply chain stability and customer inventory levels represent additional variables that could influence the outlook.

Broader economic indicators, such as consumer spending patterns and industrial production data, may provide context for interpreting any guidance provided during the call.

How I Use Tickeron’s AI Screener in My Research

When preparing for earnings like this one, I often turn to Tickeron’s AI Screener to quickly filter and compare stocks based on technical patterns, fundamentals, and AI-driven signals. It allows me to scan for similar companies in the packaging sector, review volatility metrics, and spot any emerging trends without manually combing through dozens of screens. This helps me put the upcoming report into better context by seeing how CCK stacks up against peers on key performance indicators. The tool supports customizable filters for industry, market cap, and price patterns, which I find useful for identifying potential trade ideas or confirming my own analysis ahead of events like this earnings release. AI Screener

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: CCK

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


CCK's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for CCK turned positive on August 05, 2026. Looking at past instances where CCK's MACD turned positive, the stock continued to rise in of 52 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 16, 2026. You may want to consider a long position or call options on CCK as a result. In of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The 50-day moving average for CCK moved above the 200-day moving average on July 13, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CCK advanced for three days, in of 317 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 216 cases where CCK Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for CCK moved out of overbought territory on July 29, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 38 similar instances where the indicator moved out of overbought territory. In of the 38 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CCK declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CCK broke above its upper Bollinger Band on July 16, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CCK’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.593) is normal, around the industry mean (6.707). P/E Ratio (17.424) is within average values for comparable stocks, (30.620). Projected Growth (PEG Ratio) (0.637) is also within normal values, averaging (0.957). CCK has a moderately low Dividend Yield (0.011) as compared to the industry average of (0.031). P/S Ratio (1.033) is also within normal values, averaging (1.112).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CCK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock better than average.

Industry description

The containers/packing sector includes companies that manufacture containers (like plastic and aluminum food containers, glass bottles, metal cans, cardboard, storage and waste bags, giftwraps etc.) and provide packing services. Food-and-beverage and household products are major markets for this business. Several companies in this industry cater to international markets in addition to serving domestic customers. Consumer spending habits could potentially affect this industry’s performance. Some products, that use oil-based materials as inputs, are likely to see their costs of production get impacted (to some extent) by energy price movements. The ever-expanding e-commerce market has only supercharged the amount/frequency of goods shipped domestically and across borders, thereby creating ample potential opportunities for containers and packaging businesses. Ball Corporation, International Paper Company, Amcor Plc and Packaging Corporation of America are some of the largest U.S. companies in this industry.

Market Cap

The average market capitalization across the Containers/Packaging Industry is 7.56B. The market cap for tickers in the group ranges from 6.74K to 66.8B. STO holds the highest valuation in this group at 66.8B. The lowest valued company is EPTI at 6.74K.

High and low price notable news

The average weekly price growth across all stocks in the Containers/Packaging Industry was 2%. For the same Industry, the average monthly price growth was 2%, and the average quarterly price growth was 1%. ORBS experienced the highest price growth at 10%, while IP experienced the biggest fall at -6%.

Volume

The average weekly volume growth across all stocks in the Containers/Packaging Industry was -42%. For the same stocks of the Industry, the average monthly volume growth was -15% and the average quarterly volume growth was -30%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 39
P/E Growth Rating: 53
Price Growth Rating: 50
SMR Rating: 71
Profit Risk Rating: 83
Seasonality Score: -30 (-100 ... +100)
View a ticker or compare two or three
CCK
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a company which engages in designing, manufacturing of steel and aluminum cans

Industry ContainersPackaging

Profile
Details
Industry
Containers Or Packaging
Address
14025 Riveredge Drive
Phone
+1 215 698-5100
Employees
25000
Web
https://www.crowncork.com
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.